apomorphine has been researched along with physostigmine in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 53 (73.61) | 18.7374 |
1990's | 15 (20.83) | 18.2507 |
2000's | 1 (1.39) | 29.6817 |
2010's | 3 (4.17) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bryan, J; Cheung, CY; Haggarty, SJ; Healey, D; Kim, S; Kokel, D; Laggner, C; Macrae, CA; Mateus, R; Peterson, RT; Shoichet, B; Werdich, AA; White, R | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Carroll, BJ; Curtis, GC; Kokmen, E | 1 |
Andén, NE; Wachtel, H | 1 |
Chan, SH | 1 |
Lassen, JB | 1 |
Maeno, H; Sano, K; Usuda, S | 1 |
Christensen, AV; Nielsen, IM | 1 |
Carolei, A; Margotta, V; Palladini, G | 1 |
Lai, C; Tolosa, ES | 1 |
Anlezark, GM; Marsden, CD; Meldrum, BS | 1 |
Delini-Stula, A | 1 |
Marsden, CD; Milson, J; Pycock, C; Tarsy, D | 1 |
Barr, JK; Growdon, JH; Millington, WR; Sahakian, BJ; Wurtman, RJ | 1 |
Funk, KF; Staib, AH; Westermann, KH | 1 |
Cavalheiro, EA; Izquierdo, I | 1 |
Chang, S; Crayton, JW; Ericksen, SE; Klass, D; Smith, RC | 1 |
Dunstan, R; Jackson, DM | 1 |
Fujiwara, M; Inoue, K; Ueki, S | 1 |
Holmgren, B; Urbá-Holmgren, R; Valdés, M | 1 |
Fujiwara, M; Ibii, N; Inoue, K; Kataoka, Y; Ueki, S | 1 |
Code, RA; Tang, AH | 1 |
Bourson, A; Moser, PC | 2 |
Borsini, F; Dapporto, P; Giannotti, D; Lecci, A; Meli, A; Paoli, P; Pestellini, V; Sbraci, P; Viti, G; Volterra, G | 1 |
Elis, J; Starec, M; Waitzová, D | 1 |
Poursoltan, M; Zarrindast, MR | 1 |
Berendsen, HH; Broekkamp, CL; Gower, AJ | 1 |
Hara, T; Kaneyuki, H; Kishimoto, O; Mizuki, Y; Soeda, K; Tsutsumi, C; Ushijima, I; Yamada, M | 1 |
Aihara, H; Hashimoto, S; Okuyama, S; Shimamura, H | 1 |
Laping, NJ; Ramirez, VD | 1 |
Mizuki, Y; Ushijima, I; Yamada, M | 1 |
Kishimoto, O | 1 |
Goldberg, LI; Kamien, JB; Woolverton, WL | 1 |
Furukawa, T; Imaizumi, J; Mizuki, Y; Noda, Y; Ushijima, I; Yamada, K; Yamada, M | 1 |
Parker, LA; Smith, RJ | 1 |
Carlsson, A; Kehr, W; Lindqvist, M | 1 |
Adejoh, PO; Osuide, G | 1 |
Cheng, HC; Long, JP | 1 |
Dlabac, A; Metys, J; Metysová, J | 1 |
Morrison, CF; Stephenson, JA | 1 |
Scheel-Krüger, J | 1 |
Persson, T; Waldeck, B | 1 |
Pedersen, V | 1 |
Herman, ZS; Plech, A; Stachura, Z; Wieloch-Depta, L | 1 |
Aoki, H; Kamata, K; Kameyama, T | 1 |
Colboc, O; Costentin, J; Dubuc, I; Protais, P | 1 |
Ellinwood, EH; Gonzalez, LP | 1 |
Mizuki, Y; Noda, Y; Ushijima, I; Yamada, M | 1 |
Lapierre, YD; Rastogi, RB; Rastogi, SK; Singhal, RL | 1 |
Helmreich, I; Hertting, G; Reimann, W; Starke, K | 1 |
Ando, K; Matsui, K | 1 |
Furukawa, T; Inoue, T; Noda, Y; Tokunaga, T; Ushijima, I; Yamada, K | 1 |
Bergmann, KJ; Clough, CG; Yahr, MD | 1 |
Agnoli, A; Chase, TN; Denaro, A; Ruggieri, S; Tamminga, CA | 1 |
Furukawa, T; Yamada, K | 1 |
Bures, J; Buresová, O | 1 |
Holmgren, B; Urbá-Holmgren, R | 1 |
Caffarri, G; Capretti, L; Chiodera, P; Coiro, V; Colla, R; Vescovi, PP; Volpi, R | 1 |
Braz, S; de Luca Nathan, C; de Medeiros, R; Hipólide, DC; Lobo, LL; Neumann, B; Suchecki, D; Troncone, LR; Tufik, S | 1 |
Cmielewski, PL; Gourlay, GK; Harvey, I; Odontiadis, J; Plummer, JL | 1 |
Eguíbar, JR; Holmgren, B; Santos, A; Urbá-Holmgren, R | 1 |
Mamanpush, SM; Rashidy-Pour, A; Zarrindast, MR | 1 |
Kobayashi, H; Yamaguchi, Y | 1 |
Comoy, E; Mocaër, E; Protais, P; Windsor, M | 1 |
Himes, CS; Tang, AH | 1 |
Aquino, R; Cubeddu, LX; Hoffmann, IS; Talmaciu, RK | 1 |
Hirano, H; Kaneyuki, H; Kawano, M; Mizuki, Y; Suetsugi, M; Usami, K; Ushijima, I; Yamada, M | 1 |
Szymczyk, H; Wielosz, M | 1 |
Bani-Assadi, S; Ghazi-Khansari, M; Rezvani, N; Zarrindast, MR | 1 |
1 review(s) available for apomorphine and physostigmine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for apomorphine and physostigmine
Article | Year |
---|---|
Meige disease: striatal dopaminergic preponderance.
Topics: Aged; Apomorphine; Basal Ganglia; Blepharospasm; Clinical Trials as Topic; Diagnosis, Differential; Eyelid Diseases; Facial Muscles; Female; Haloperidol; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Physostigmine; Placebos | 1979 |
Dopaminergic and cholinergic control of arginine-vasopressin secretion in type I diabetic men.
Topics: Acetylcholine; Adult; Apomorphine; Arginine Vasopressin; Blood Pressure; Diabetes Mellitus, Type 1; Dopamine; Humans; Male; Physostigmine | 1995 |
69 other study(ies) available for apomorphine and physostigmine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Rapid behavior-based identification of neuroactive small molecules in the zebrafish.
Topics: | 2010 |
Paradoxical response to dopamine agonists in tardive dyskinesia.
Topics: Adrenergic alpha-Agonists; Adult; Amantadine; Apomorphine; Benztropine; Clozapine; Deanol; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Antagonism; Drug Tolerance; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Levodopa; Physostigmine; Receptors, Dopamine; Reserpine; Stimulation, Chemical; Thioridazine | 1977 |
Increase in the turnover of brain dopamine by stimulation of muscarinic receptors outside the dopamine nerve terminals.
Topics: 4-Butyrolactone; Animals; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Atropine; Atropine Derivatives; Brain; Corpus Striatum; Dopamine; Hydrazines; Male; Nerve Endings; Norepinephrine; Oxotremorine; Physostigmine; Rats; Receptors, Cholinergic; Receptors, Muscarinic | 1977 |
Central neurotransmitter systems in the morphine suppression of jaw-opening reflex in rabbits: the dopaminergic system.
Topics: Animals; Apomorphine; Dopamine; Dopamine Antagonists; Haloperidol; Jaw; Morphine; Neurotransmitter Agents; Pain; Physostigmine; Pimozide; Rabbits; Reflex | 1979 |
Inhibition of apomorphine-induced climbing in mice by cholinergic drugs and neuroleptics.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Clozapine; Female; Haloperidol; Injections, Intramuscular; Mice; Oxotremorine; Parasympathomimetics; Physostigmine | 1979 |
Pharmacological and biochemical studies on a new potential neuroleptic, N-(1-benzyl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-08050).
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzamides; Catalepsy; Chlorpromazine; Dogs; Dopamine; Drug Interactions; Female; Haloperidol; Humans; Male; Methamphetamine; Mice; Physostigmine; Rats; Stereotyped Behavior; Synaptic Membranes | 1979 |
Dopaminergic supersensitivity: influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia.
Topics: Animals; Antiparkinson Agents; Apomorphine; Atropine; Dopamine; Drug Synergism; Dyskinesia, Drug-Induced; Flupenthixol; Humans; Male; Methylphenidate; Mice; Muscimol; Parasympatholytics; Parasympathomimetics; Phenobarbital; Physostigmine; Stereotyped Behavior | 1979 |
Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations.
Topics: Acetylcholine; Animals; Apomorphine; Atropine; Benserazide; Bromocriptine; Central Nervous System; Dextroamphetamine; Dopamine; Extrapyramidal Tracts; Haloperidol; Levodopa; Models, Neurological; Motor Activity; Physostigmine; Piribedil; Planarians; Reserpine; Synaptic Transmission; Turbellaria | 1975 |
Acute dystonia as an idiosyncratic response to neuroleptics in baboons.
Topics: 5-Hydroxytryptophan; Acute Disease; Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Haloperidol; Haplorhini; Humans; Levodopa; Movement Disorders; Papio; Parasympatholytics; Physostigmine; Pimozide; Receptors, Dopamine; Reserpine; Syndrome; Tranquilizing Agents | 1977 |
Baclofen-induced modification of conditioned discriminative avoidance behaviour and contraversive turning in the rat.
Topics: Aminobutyrates; Animals; Apomorphine; Avoidance Learning; Baclofen; Behavior; Discrimination, Psychological; Humans; Hydroxydopamines; Male; Physostigmine; Rats; Stereotyped Behavior; Time Factors | 1977 |
The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic system.
Topics: Animals; Apomorphine; Behavior; Corpus Striatum; Dextroamphetamine; Dopamine; Drug Interactions; Humans; Male; Mice; Mice, Inbred Strains; Parasympathetic Nervous System; Physostigmine; Scopolamine; Scopolamine Derivatives; Stereotyped Behavior; Substantia Nigra | 1978 |
The effects of cholinergic agonists on apomorphine-induced stereotyped behavior in the rat.
Topics: Acetylcholine; Animals; Apomorphine; Arecoline; Behavior; Choline; Corpus Striatum; Dose-Response Relationship, Drug; Humans; Male; Physostigmine; Pilocarpine; Rats; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Muscarinic; Stereotyped Behavior | 1978 |
Asymmetric behaviour induced in caudate nucleus lesioned mice: interaction of aminergic and cholinergic agents.
Topics: Animals; Apomorphine; Behavior, Animal; Brain; Caudate Nucleus; Dopamine; Female; Functional Laterality; Hydroxyindoleacetic Acid; Male; Mice; Nicotine; Oxotremorine; Parasympathomimetics; Physostigmine; Scopolamine; Serotonin | 1978 |
Three main factors in rat shuttle behavior: their pharmacology and sequential entry in operation during a two-way avoidance session.
Topics: Animals; Apomorphine; Atropine; Atropine Derivatives; Avoidance Learning; Clonidine; Conditioning, Classical; Conditioning, Operant; Drive; Female; Haloperidol; Male; Nicotine; Phenoxybenzamine; Physostigmine; Rats | 1976 |
Electrophysiological (H-reflex) studies of patients with tardive dyskinesia.
Topics: Amphetamine; Apomorphine; Deanol; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Electrophysiology; H-Reflex; Humans; Motor Neurons; Muscles; Neurons, Afferent; Physostigmine; Receptors, Dopamine; Reflex, Monosynaptic; Schizophrenia | 1977 |
The demonstration of a change in responsiveness of mice to physostigmine and atropine after withdrawal from long-term haloperidol pretreatment.
Topics: Animals; Apomorphine; Atropine; Dose-Response Relationship, Drug; Haloperidol; Male; Mice; Motor Activity; Physostigmine; Premedication; Receptors, Cholinergic; Receptors, Dopamine | 1977 |
[Behavioral pharmacology of a new antidepressant, lopramine].
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Apomorphine; Avoidance Learning; Blepharoptosis; Body Temperature; Catalepsy; Dibenzazepines; Drug Synergism; Emotions; Humans; Imipramine; Lethal Dose 50; Levodopa; Male; Methamphetamine; Mice; Motor Activity; Muscle Relaxation; Oxotremorine; Physostigmine; Rats; Stereotyped Behavior | 1976 |
Relative role of catecholamines in head-shaking of infant rats.
Topics: Animals; Animals, Newborn; Apomorphine; Behavior; Catecholamines; Chlorpromazine; Dextroamphetamine; Drug Interactions; Female; Haloperidol; Humans; Male; Motor Activity; Phenoxybenzamine; Physostigmine; Propranolol; Rats; Stereotyped Behavior | 1976 |
[Behavior pharmacology of maprotiline, a new antidepressant].
Topics: Aggression; Amitriptyline; Animals; Anthracenes; Apomorphine; Behavior, Animal; Body Temperature; Catalepsy; Escape Reaction; Eyelids; Haloperidol; Humans; Imipramine; Levodopa; Maprotiline; Methamphetamine; Mice; Motor Activity; Oxotremorine; Physostigmine; Rats; Reserpine; Sleep; Tetrabenazine | 1975 |
Yawning produced by dopamine agonists in rhesus monkeys.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Dopamine; Dopamine Agents; Dopamine Antagonists; Ergolines; Macaca mulatta; Male; Physostigmine; Piperidines; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Yawning | 1991 |
Yawning induced by apomorphine, physostigmine or pilocarpine is potentiated by dihydropyridine calcium channel blockers.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Apomorphine; Atropine; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Drug Synergism; Male; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Receptors, Dopamine; Sulpiride; Yawning | 1990 |
New dibenzothiadiazepine derivatives with antidepressant activities.
Topics: Animals; Antidepressive Agents; Apomorphine; Body Temperature; Indicators and Reagents; Magnetic Resonance Spectroscopy; Male; Mice; Models, Molecular; Molecular Conformation; Molecular Structure; Physostigmine; Reserpine; Spectrophotometry, Infrared; Structure-Activity Relationship; Thiazepines; X-Ray Diffraction | 1991 |
Effect of RG-tannin on yawning behaviour induced by apomorphine or physostigmine in rats.
Topics: Animals; Anthocyanins; Antipsychotic Agents; Apomorphine; Dose-Response Relationship, Drug; Male; Physostigmine; Proanthocyanidins; Rats; Rats, Inbred Strains; Yawning | 1989 |
The effect of pre- and postoperative procedures on physostigmine- and apomorphine-induced yawning in rats.
Topics: Animals; Apomorphine; Desipramine; Drug Interactions; Male; Medial Forebrain Bundle; Nifedipine; Pentobarbital; Physostigmine; Rats; Rats, Inbred Strains; Stress, Physiological; Surgical Procedures, Operative; Yawning | 1989 |
Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Atropine; Behavior, Animal; Benzazepines; Bromocriptine; Drug Interactions; Male; Physostigmine; Rats; Receptors, Cholinergic; Receptors, Dopamine; Theophylline; Yawning | 1989 |
Antagonism of drug-induced yawning and penile erections in rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Apomorphine; Behavior, Animal; Dose-Response Relationship, Drug; Histamine Antagonists; Male; Penile Erection; Physostigmine; Rats; Rats, Inbred Strains; Reflex; Serotonin; Serotonin Antagonists | 1986 |
[Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Apomorphine; Benzazepines; Benzhydryl Compounds; Bromocriptine; Dopamine Agents; Drug Interactions; Male; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Yawning | 1988 |
Relation between yawning behavior and central serotonergic neuronal system in rats.
Topics: 5-Hydroxytryptophan; 5,7-Dihydroxytryptamine; Animals; Apomorphine; Corpus Striatum; Dose-Response Relationship, Drug; Fenclonine; Male; Microinjections; Physostigmine; Rats; Rats, Inbred Strains; Serotonin; Yawning | 1987 |
Prolactin-induced yawning behavior requires an intact nigro-striatal dopamine system.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Corpus Striatum; Dopamine; Hydroxydopamines; Male; Oxidopamine; Physostigmine; Prolactin; Rats; Substantia Nigra; Sympathectomy, Chemical; Yawning | 1988 |
Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Apomorphine; Benzazepines; Bromocriptine; Male; Methyltyrosines; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Receptors, Dopamine; Yawning | 1988 |
[Age-related modification of dopaminergic-cholinergic neuronal interaction in rats].
Topics: Aging; Animals; Apomorphine; Drug Interactions; Male; Methyltyrosines; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Reserpine; Stereotyped Behavior; Yawning | 1988 |
Pharmacological analysis of the apomorphine discriminative stimulus in rhesus monkeys.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Cocaine; Conditioning, Operant; Dextroamphetamine; Discrimination Learning; Domperidone; Dose-Response Relationship, Drug; Female; Fluoxetine; Macaca mulatta; Male; Physostigmine; Piribedil; Quipazine; Sodium Chloride | 1987 |
Characteristics of yawning behavior induced by apomorphine, physostigmine and pilocarpine.
Topics: Animals; Apomorphine; Behavior, Animal; Haloperidol; Male; Mecamylamine; N-Methylscopolamine; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Scopolamine; Scopolamine Derivatives; Time Factors | 1985 |
Chin rub CRs are elicited by flavors associated with apomorphine, scopolamine, methscopolamine, physostigmine and neostigmine.
Topics: Animals; Apomorphine; Conditioning, Operant; Male; N-Methylscopolamine; Neostigmine; Physostigmine; Rats; Rats, Inbred Strains; Scopolamine; Scopolamine Derivatives; Taste | 1985 |
Short-term control of tyrosine hydroxylase.
Topics: Adrenal Medulla; Animals; Apomorphine; Atropine; Axons; Brain; Chlorisondamine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Epinephrine; Haloperidol; Monoamine Oxidase Inhibitors; Norepinephrine; Pargyline; Phentolamine; Physostigmine; Rats; Time Factors; Tyrosine 3-Monooxygenase | 1974 |
Effects of apomorphine and its interaction with other drugs in the domestic fowl.
Topics: Age Factors; Aggression; Animals; Animals, Newborn; Apomorphine; Atropine; Behavior, Animal; Chickens; Chlorpromazine; Dibenzazepines; Dose-Response Relationship, Drug; Drug Interactions; Electrodes, Implanted; Electromyography; Humans; Pentobarbital; Physostigmine; Reflex; Reserpine; Scopolamine; Stereotyped Behavior; Vomiting | 1973 |
Dopaminergic nature of apomorphine-induced pecking in pigeons.
Topics: Animals; Apomorphine; Aporphines; Behavior, Animal; Chlorpromazine; Columbidae; Dihydroxyphenylalanine; Dioxoles; Dopamine; Haloperidol; Imipramine; Methyltyrosines; Nicotine; Oxotremorine; Phentolamine; Physostigmine; Pilocarpine; Propranolol; Receptors, Drug; Reserpine; Serotonin; Time Factors | 1974 |
Pharmacological properties of a new potential neuroleptic drug oxyprothepin. IV. Antiadrenergic action and influence on brain monoamines.
Topics: Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Chlorpromazine; Dibenzothiepins; Dogs; Dopamine; Drug Interactions; Epinephrine; Feeding Behavior; Locomotion; Mastication; Mice; Norepinephrine; Phenmetrazine; Physostigmine; Piperazines; Rabbits; Rats; Serotonin; Tranquilizing Agents; Vomiting | 1971 |
Nicotine injections as the conditioned stimulus in discrimination learning.
Topics: Amphetamine; Animals; Apomorphine; Caffeine; Chlordiazepoxide; Chlorisondamine; Conditioning, Operant; Discrimination Learning; Electroshock; Epinephrine; Gallamine Triethiodide; Male; Mecamylamine; Nicotine; Noise; Phenobarbital; Physostigmine; Rats; Water | 1969 |
Central effects of anticholergic drugs measured by the apomorphine gnawing test in mice.
Topics: Animals; Apomorphine; Atropine; Behavior, Animal; Central Nervous System; Drug Synergism; Female; Mice; Parasympatholytics; Physostigmine; Quinuclidines; Scopolamine; Tropanes | 1970 |
Further studies on the possible interaction between dopamine and noradrenaline containing neurons in the brain.
Topics: Animals; Apomorphine; Brain; Brain Chemistry; Dopamine; Female; Imidazoles; Methyltyrosines; Mice; Mixed Function Oxygenases; Neurons; Norepinephrine; Physostigmine; Receptors, Drug; Thiocarbamates; Tyrosine | 1970 |
Potentiation of apomorphine effect (compulsive gnawing behaviour) in mice.
Topics: Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Drug Synergism; Mice; Parasympatholytics; Physostigmine | 1967 |
Effect of neuroleptics on release on acetylcholine to the lateral cerebral ventricle in the rat.
Topics: Acetylcholine; Animals; Antipsychotic Agents; Apomorphine; Cerebral Ventricles; Clonidine; Male; Physostigmine; Rats; Rats, Inbred Strains | 1981 |
Involvement of the dopaminergic system in the regulation of the caudate spindle in the rat.
Topics: Action Potentials; Animals; Antipsychotic Agents; Apomorphine; Baclofen; Caudate Nucleus; Dopamine; Drug Interactions; Male; Methysergide; Physostigmine; Picrotoxin; Rats; Rats, Inbred Strains; Time Factors | 1982 |
Antagonism of the apomorphine-induced yawning by "atypical" neuroleptics.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Clozapine; Dopamine; Dose-Response Relationship, Drug; Male; Physostigmine; Rats; Rats, Inbred Strains; Sulpiride | 1982 |
Cholinergic modulation of stimulant-induced behavior.
Topics: Amphetamine; Animals; Apomorphine; Behavior, Animal; Central Nervous System Stimulants; Drug Interactions; Humans; Male; Methylphenidate; Motor Activity; Neurons; Parasympathetic Nervous System; Physostigmine; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1984 |
Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Haloperidol; Humans; Male; Parasympathomimetics; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Receptors, Cholinergic; Receptors, Dopamine; Scopolamine; Stereotyped Behavior | 1984 |
Effects of cholinergic and GABAergic drugs on apomorphine-induced gnawing behavior in rats.
Topics: Aminooxyacetic Acid; Animals; Apomorphine; Atropine; Dose-Response Relationship, Drug; Humans; Male; Mastication; Parasympathomimetics; Physostigmine; Picrotoxin; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, GABA-A; Stereotyped Behavior | 1982 |
Are presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in the rabbit caudate nucleus pharmacologically different?
Topics: Acetylcholine; Animals; Apomorphine; Atropine; Carbachol; Caudate Nucleus; Choline; Dopamine; Electric Stimulation; Female; Male; Membrane Potentials; Metoclopramide; Molindone; Physostigmine; Rabbits; Receptors, Dopamine; Sulpiride; Synapses; Synaptic Transmission | 1982 |
[The antiataxic mechanism of TRH in rolling mouse Nagoya: the effects of pretreatment with dopaminergic and cholinergic drugs].
Topics: Animals; Animals, Laboratory; Apomorphine; Ataxia; Atropine; Drug Synergism; Gait; Mice; Mice, Neurologic Mutants; Motor Activity; Physostigmine; Pimozide; Rodent Diseases; Thyrotropin-Releasing Hormone | 1984 |
Muscarinic and nicotinic effects on yawning and tongue protruding in the rat.
Topics: Animals; Apomorphine; Behavior, Animal; Drug Interactions; Ganglionic Stimulants; Humans; Male; Parasympathomimetics; Physostigmine; Pilocarpine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Tongue | 1984 |
Cholinergic and dopaminergic mechanisms in Parkinson's disease after long-term L-DOPA administration.
Topics: Acetylcholine; Adult; Aged; Antiparkinson Agents; Apomorphine; Brain; Dopamine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Physostigmine; Time Factors | 1984 |
State of DA/ACh balance after chronic treatment with haloperidol and with THIP in rats.
Topics: Acetylcholine; Animals; Apomorphine; Atropine; Behavior, Animal; Brain; Dopamine; Haloperidol; Isoxazoles; Male; Oxazoles; Physostigmine; Rats; Rats, Inbred Strains | 1984 |
Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning.
Topics: Animals; Apomorphine; Behavior, Animal; Dopamine Antagonists; Fluphenazine; Humans; Male; Parasympathetic Nervous System; Physostigmine; Pilocarpine; Rats; Reflex; Reserpine; Scopolamine; Stereotyped Behavior | 1980 |
Radial maze as a tool for assessing the effect of drugs on the working memory of rats.
Topics: Amphetamine; Animals; Apomorphine; Male; Memory; Physostigmine; Piracetam; Rats; Scopolamine | 1982 |
Interaction of cholinergic and dopaminergic influences on yawning behavior.
Topics: Animals; Apomorphine; Behavior, Animal; Benzofurans; Citalopram; Fluoxetine; Metergoline; Physostigmine; Propylamines; Rats; Receptors, Cholinergic; Receptors, Dopamine; Scopolamine; Spiperone | 1980 |
Effects of stress on drug-induced yawning: constant vs. intermittent stress.
Topics: Animals; Apomorphine; Arousal; Brain; Dose-Response Relationship, Drug; Male; Physostigmine; Pilocarpine; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Receptors, Dopamine; Stress, Psychological; Yawning | 1995 |
Behavioural effects of norpethidine, a metabolite of pethidine, in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Brain Chemistry; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Male; Meperidine; Physostigmine; Random Allocation; Rats; Rats, Wistar; Reserpine | 1995 |
Two inbred rat sublines that differ in spontaneous yawning behavior also differ in their responses to cholinergic and dopaminergic drugs.
Topics: Animals; Apomorphine; Dopamine Agents; Dose-Response Relationship, Drug; Male; Parasympathomimetics; Physostigmine; Pilocarpine; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic; Receptors, Dopamine; Species Specificity; Yawning | 1993 |
Morphine inhibits dopaminergic and cholinergic induced ejaculation in rats.
Topics: Animals; Apomorphine; Atropine; Cholinergic Agents; Dopamine Agents; Ejaculation; Ergolines; Male; Morphine; Naloxone; Physostigmine; Pilocarpine; Quinpirole; Rats; Sulpiride | 1994 |
Effects of apomorphine, physostigmine and vasoactive intestinal peptide on penile erection and yawning in diabetic rats.
Topics: Administration, Topical; Animals; Apomorphine; Catheterization; Diabetes Mellitus, Experimental; Grooming; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Subcutaneous; Male; Penile Erection; Physostigmine; Rats; Rats, Wistar; Vasoactive Intestinal Peptide; Yawning | 1994 |
Post-synaptic 5-HT1A receptor involvement in yawning and penile erections induced by apomorphine, physostigmine and mCPP in rats.
Topics: Adrenergic beta-Antagonists; Animals; Apomorphine; Dose-Response Relationship, Drug; Herbicides; Male; Penile Erection; Physostigmine; Piperazines; Presynaptic Terminals; Propanolamines; Rats; Rats, Wistar; Receptors, Serotonin; Thiophenes; Yawning | 1995 |
Apomorphine produced more yawning in Sprague-Dawley rats than in F344 rats: a pharmacological study.
Topics: Adrenergic alpha-Antagonists; Animals; Apomorphine; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Injections, Subcutaneous; Male; Parasympathomimetics; Physostigmine; Pindolol; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Reserpine; Species Specificity; Stereotyped Behavior; Sympatholytics; Yawning | 1995 |
Differential effects of muscarinic receptor agonists and phorbol ester on muscarinic and D2-dopamine release-modulatory receptors.
Topics: Animals; Apomorphine; Carbachol; Dopamine; Dose-Response Relationship, Drug; Female; Male; Muscarinic Agonists; Phorbol Esters; Physostigmine; Rabbits; Receptors, Dopamine D2 | 1996 |
Dopaminergic and cholinergic interaction in cataleptic responses in mice.
Topics: Animals; Apomorphine; Benzazepines; Catalepsy; Cholinergic Antagonists; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Male; Mice; Mice, Inbred Strains; Parasympathetic Nervous System; Parasympathomimetics; Physostigmine; Pilocarpine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Muscarinic; Scopolamine | 1997 |
Yawning induced by apomorphine, physostigmine or pilocarpine is inhibited by electroconvulsive shock (ECS).
Topics: Animals; Apomorphine; Dopamine Agonists; Electroshock; Male; Parasympathomimetics; Physostigmine; Pilocarpine; Rats; Rats, Wistar; Yawning | 1996 |
Effects of lead exposure on licking and yawning behaviour in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Cholinesterase Inhibitors; Dopamine Agonists; Dose-Response Relationship, Drug; Lead Poisoning; Male; Organometallic Compounds; Physostigmine; Poisons; Rats; Rats, Wistar; Yawning | 1998 |